Frost Radar: Clinical Documentation Integrity in North America, 2025

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, and utilization management staff in enhancing care personalization; mitigating adverse events, such as medication reconciliation errors; and improving reimbursement efficiency.

CDI, which is an integral part of revenue cycle management, is a strategic imperative in healthcare, extending beyond its role in claims processing and denials management. It enhances patient outcomes, ensures data accuracy to reflect the true care narrative, supports precise reimbursement, and strengthens compliance risk management and revenue integrity.

As new-age CDI vendors prioritize the adoption of cutting-edge technology, such as conversational AI, AI clinical assistant in medical coding, and the use of ambient AI in clinical documentation and machine learning and natural language processing in autonomous coding, it has become imperative for electronic health record-based and legacy CDI providers to stay competitive and redefine their clinical documentation tools to support next-generation workflows across the healthcare continuum.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.